Amanote Research
Register
Sign In
Patient Preferences Regarding Monitoring and Treatment for the Management of Neovascular Age-Related Macular Degeneration
Value in Health
- United Kingdom
doi 10.1016/j.jval.2013.08.1177
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2013
Authors
A. Ferreira
A. Lall
A. Squire
L. Gregg
A. Graham
Publisher
Elsevier BV
Related search
Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration
Ophthalmology
Ophthalmology
Development and Testing of a Patient-Derived Questionnaire for Treatment of Neovascular Age-Related Macular Degeneration: Dimensions of Importance in Treatment of Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Optical Coherence Tomography for the Monitoring of Neovascular Age-Related Macular Degeneration
Ophthalmology
Ophthalmology
Treatment of Age-Related Neovascular Macular Degeneration: The Patient’s Perspective
Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Aflibercept for Neovascular Age-Related Macular Degeneration
Cochrane Database of Systematic Reviews
New Molecular Targets for the Treatment of Neovascular Age-Related Macular Degeneration
Translational Medicine Reports
Macular Atrophy in Neovascular Age Related Macular Degeneration
Journal of Clinical Review & Case Reports
Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine
Medicine
Pss62 - Treatment Preference Drivers of Patients With Neovascular Age-Related Macular Degeneration
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
